2019 annual financial data
Vivos Therapeutics 2019 Net margin
Direct answer
Net margin was -94.39%.
Operating income was -10,577,233 USD and net income was -10,754,319 USD.
Operating cash flow was -5,340,480 USD.
Get free Vivos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 11,393,277 USD
- Operating income
- -10,577,233 USD
- Net income
- -10,754,319 USD
- Operating cash flow
- -5,340,480 USD